Le Lézard
Classified in: Health
Subject: PSF

Public Advisory - Unauthorized skin lightening products seized from Beauty Haven Canada, in Oshawa, ON, because they may pose serious health risks


OTTAWA, ON, Dec. 28, 2022 /CNW/ - Health Canada is advising that the following product(s) may pose serious health risks. For more information, including what you should do, visit the online safety alert.

Health Canada maintains a list of unauthorized health products that may pose serious health risks so that the public can easily identify those they may have purchased and take appropriate action. You are encouraged to check back regularly for updates.

Unauthorized health products

Product &
Promoted Use

Hazard Identified

Company

Action Taken

Brilliant Skin Essentials
Brilliant Rejuv Set

Skin lightening

Labelled to contain
hydroquinone and tretinoin

Beauty Haven Canada

Oshawa, ON

Seized from the
warehouse location and
removed from online sale

Brilliant Skin Essentials
Brilliant Rejuv Topical Solution

Skin lightening

Labelled to contain
hydroquinone and tretinoin

Beauty Haven Canada

Oshawa, ON

Seized from the
warehouse location and
removed from online sale

Brilliant Skin Essentials
Brilliant Rejuv Topical Cream

Skin lightening

Labelled to contain
hydroquinone and tretinoin

Beauty Haven Canada

Oshawa, ON

Seized from the
warehouse location and
removed from online sale

Images
For photos of these products, please visit the online safety alert.

Stay connected with Health Canada and receive the latest advisories and product recalls.

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 22:03
Anti-Mullerian Hormone Test Market Projected to Reach $586.48 million by 2030 - Exclusive Report by 360iResearch
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co.
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
Greenberg Traurig's David Dykeman and Roman Fayerberg to Present at DeviceTalks Boston
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance Provides Notice Following Data Security Incident
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

More news about Health...


News published on and distributed by: